As a heterogeneous disease, breast cancer can be divided into 3 major subtypes in terms of molecular markers for estrogen or progesterone receptors and human epidermal growth factor 2 (ERBB2; formerly HER2) [35]. The gene discussed is ERBB2; the disease is breast carcinoma.